September 2025
1. ZIEGLER DA, Ambold M, Schirmer MA, Droge LH, et al
   The abscopal effect in metastatic lung cancer: a retrospective analysis of combined radiotherapy and immunotherapy.
   Clin Exp Metastasis. 2025;42:56.
   

   >> Share

   
   August 2025
2. CHENG L, Li S, Cui Z, Sun X, et al
   G-protein coupled receptor 183 (GPR183) inhibits visceral metastasis of non-small cell lung cancer.
   Clin Exp Metastasis. 2025;42:44.
   

   >> Share

   
   July 2025
3. BOZORGMEHR F, Chung I, Fischer JR, Bischof M, et al
   Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415).
   Clin Exp Metastasis. 2025;42:42.
   

   >> Share

   
   May 2025
4. YANG X, Chu X, Ye R, Ni J, et al
   Oligo-residual disease in metastatic ALK-positive NSCLC treated with alectinib.
   Clin Exp Metastasis. 2025;42:31.
   

   >> Share

   
   April 2025
5. ROQUET N, Beddok A, Loo M, Calais G, et al
   Post-operative hypofractionated stereotactic radiotherapy for brain metastases from lung and breast cancer in patients without prior WBRT: a retrospective dose escalation study.
   Clin Exp Metastasis. 2025;42:27.
   

   >> Share

   
   
6. YANG L, Li J
   Interplay of GPC3, Hsa-miR-135b-3p, and FTLP3 in lung cancer metastasis.
   Clin Exp Metastasis. 2025;42:26.
   

   >> Share

   
   March 2025
7. YANG J, Feng J, Duan Z, Liu X, et al
   Brain metastases lung adenocarcinoma patients with BRG1 loss have a grim prognosis, featuring unique morphological and methylation characteristics.
   Clin Exp Metastasis. 2025;42:20.
   

   >> Share

   
   
8. LIU Z, Song H, Wang Z, Hu Y, et al
   A novel optimized orthotopic mouse model for brain metastasis with sustained cerebral blood circulation and capability of multiple delivery.
   Clin Exp Metastasis. 2025;42:19.
   

   >> Share

   
   December 2024
9. RIZZO A, Monteiro FSM, Mollica V, Brunetti O, et al
   Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study.
   Clin Exp Metastasis. 2024;42:9.
   

   >> Share

   
   
10. HU X, Wu H, Hu K, Kang Y, et al
    Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment.
    Clin Exp Metastasis. 2024;42:8.
    

    >> Share

    
    
11. JASMER KJ, Shanbhag VC, Forti KM, Woods LT, et al
    Pulmonary lysyl oxidase expression and its role in seeding Lewis lung carcinoma cells.
    Clin Exp Metastasis. 2024;42:7.
    

    >> Share

    
    
12. SONG Y, Kim YJ, Choi S, Yun JK, et al
    Stereotactic ablative radiotherapy for pulmonary metastasis from sarcoma: a retrospective comparison with metastasectomy.
    Clin Exp Metastasis. 2024;42:2.
    

    >> Share

    
    
13. CAIVANO D, Pezzulla D, Bonome P, Ricciardi C, et al
    Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy.
    Clin Exp Metastasis. 2024;42:4.
    

    >> Share

    
    
14. HUNG SK, Yu CC, Lin HY, Chiou WY, et al
    Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis.
    Clin Exp Metastasis. 2024;41:925-935.
    

    >> Share

    
    October 2024
15. HU Y, Lei W, Xin E, Cheng T, et al
    Factors associated with the distribution of brain metastases in lung cancer: a retrospective study.
    Clin Exp Metastasis. 2024 Oct 1. doi: 10.1007/s10585-024-10315.
    

    >> Share

    
    May 2024
16. BAUGH AG, Gonzalez E, Narumi VH, Kreger J, et al
    A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer.
    Clin Exp Metastasis. 2024 May 8. doi: 10.1007/s10585-024-10289.
    

    >> Share

    
    April 2024
17. BHAT V, Piaseczny M, Goodale D, Patel U, et al
    Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis.
    Clin Exp Metastasis. 2024 Apr 6. doi: 10.1007/s10585-024-10284.
    

    >> Share

    
    
18. HAIDER MT, Freytag V, Krause L, Spethmann T, et al
    Comparison of ex vivo bioluminescence imaging, Alu-qPCR and histology for the quantification of spontaneous lung and bone metastases in subcutaneous xenograft mouse models.
    Clin Exp Metastasis. 2024;41:103-115.
    

    >> Share

    
    March 2024
19. OKUNO T, Isobe T, Tsubata Y
    Current pharmacologic treatment of brain metastasis in non-small cell lung cancer.
    Clin Exp Metastasis. 2024 Mar 11. doi: 10.1007/s10585-024-10276.
    

    >> Share

    
    February 2024
20. WIEGMANS AP, Ivanova E, Naei VY, Monkman J, et al
    Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer.
    Clin Exp Metastasis. 2024 Feb 28. doi: 10.1007/s10585-024-10270.
    

    >> Share

    
    
21. POURJAMAL N, Yazdi N, Halme A, Joncour VL, et al
    Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model.
    Clin Exp Metastasis. 2024 Feb 17. doi: 10.1007/s10585-024-10278.
    

    >> Share

    
    
22. POPOV P, Steindl A, Wolff L, Bergen ES, et al
    Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center.
    Clin Exp Metastasis. 2024;41:25-32.
    

    >> Share

    
    January 2024
23. HORIMOTO Y, Hlaing MT, Saeki H, Denda-Nagai K, et al
    Glycosylation profiles of breast cancer cells may represent clonal variations of multiple organ metastases.
    Clin Exp Metastasis. 2024 Jan 9. doi: 10.1007/s10585-023-10253.
    

    >> Share

    
    December 2023
24. BENZEKRY S, Schlicke P, Mogenet A, Greillier L, et al
    Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases.
    Clin Exp Metastasis. 2023 Dec 20. doi: 10.1007/s10585-023-10245.
    

    >> Share

    
    October 2023
25. OYOSHI H, Hirata H, Hirano Y, Zenda S, et al
    Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy.
    Clin Exp Metastasis. 2023;40:407-413.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share